Kaiser Permanente allocates $8 million for IHI scholarship program

Kaiser Permanente will provide an $8 million endowment to the Institute for Healthcare Improvement (IHI) that funds new scholarship programs to allow healthcare professionals to participate in IHI healthcare improvement programs including conferences, training courses and collaborative learning sessions. IHI programs focus on issues such as clinical outcomes, patient safety, patient satisfaction, office and hospital redesign, health disparities, and healthcare access.
   
Kaiser Permanente said that approximately half of the scholarships funded by the endowment will be made available for IHI and Kaiser Permanente to distribute to non-Kaiser Permanente teams. The remaining half of the scholarships will be given to teams from Kaiser Permanente to support healthcare improvement efforts to benefit the organization's 8 million-plus members. Distributions from the $8 million endowment, including appreciation, will be used on an annual basis to continually fund the scholarship program.
   
Kaiser Permanente's $8 million endowment is part of a $10 million agreement that includes $2 million to fund IHI activities within Kaiser Permanente over the next two to three years. The activities may include leadership-level planning sessions, work with dedicated IHI faculty regarding patient safety, idealized design and workflow, leveraging information technology for improvement, and transfer of knowledge and improvement between organizations.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.